Form 4: Veracyte GC Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Veracyte's SVP and General Counsel, Annie McGuire, reported the sale of common stock totaling 1,422 shares under a pre-arranged 10b5-1 trading plan, alongside a tax-related disposition.
Summary
- Annie McGuire, SVP, General Counsel of Veracyte, Inc. (VCYT), reported transactions involving the company's common stock.
- On December 2, 2025, 3,052 shares of common stock were disposed of at $46.16 per share to satisfy tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a sale.
- On December 4, 2025, a total of 1,422 shares of common stock were sold in two separate transactions.
- The first sale on December 4, 2025, involved 720 shares at a weighted average price of $47.0955 per share, with individual sale prices ranging from $46.50 to $47.48.
- The second sale on December 4, 2025, involved 702 shares at $47.51 per share.
- Both sales on December 4, 2025, were executed pursuant to a Rule 10b5-1 trading plan adopted by Ms. McGuire on September 4, 2024.
- Following these reported transactions, Ms. McGuire beneficially owns 78,499 shares of Veracyte common stock directly.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions, including tax-related dispositions and sales under a pre-arranged 10b5-1 plan, which are generally considered neutral events and do not indicate a change in company fundamentals or management's outlook.
Industry Context
This filing represents a routine insider transaction for a biotechnology company, where executives often manage their equity compensation through pre-arranged trading plans to comply with insider trading regulations and manage personal finances.
Stakeholder Impact
- Minimal direct impact on shareholders as these are routine, pre-planned insider transactions. The sales are not indicative of a change in company performance or outlook.
Key Dates
| Date | Description |
|---|---|
| 09/04/2024 | Date Reporting Person adopted Rule 10b5-1 plan. |
| 12/02/2025 | Date of disposition of shares for tax withholding related to RSU vesting. |
| 12/04/2025 | Date of common stock sales under Rule 10b5-1 plan and filing signature date. |
Keywords
Veracyte, VCYT, Annie McGuire, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Restricted Stock Units, Tax Withholding, Corporate Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.